Federal Register Notice: FDA is seeking public comment on the information collection provisions of the agency’s requirements on content and format of labeling for human prescription drug and biological products. Comments should be submitted by 11/28. FDA published a final rule entitled “Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products” 1/24/06 to make it easier for health care practitioners to access, read, and use information in prescription drug labeling; to enhance the safe and effective use of prescription drug products; and to reduce the number of adverse reactions resulting from medication errors due to misunderstood or incorrectly applied drug information. To view this notice, click here.